Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-based inhibitor design targeting HIV-1 integrase.

I-Jen Chen1, Nouri Neamati, Alexander D MacKerell

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 N. Pine Street, Baltimore, MD 21201, USA. i.chen@ribotargets.com

Current Drug Targets. Infectious Disorders
|December 5, 2002
PubMed
Summary

Computer-aided drug design targets HIV integrase (IN), a key protein for viral DNA integration. This review covers IN

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Interpretation of Temperature-Induced DNA Melting Monitored through Base Dipole Moment Changes as a Surrogate of the Hypochromic Shift.

The journal of physical chemistry letters·2026
Same author

Agonist-specific conformational dynamics at the β<sub>2</sub>-adrenoceptor dictate allosteric modulation of Gαs signalling and bronchodilation.

British journal of pharmacology·2026
Same author

Targeting conserved domains of hypoxia-inducible factors for cancer therapy.

The Journal of experimental medicine·2026
Same author

The scientific legacy of Martin Karplus from the perspective of his collaborators.

Biophysical journal·2026
Same author

Computational Ligand-Binding Site Prediction.

Advances in experimental medicine and biology·2026
Same author

First-in-Class Potent, Dual HDAC6/Proteasome Inhibitors Lacking a Hydroxamic Acid Motif: Discovery of Novel Anti-Multiple Myeloma Agents.

ACS medicinal chemistry letters·2026

Area of Science:

  • Virology
  • Structural Biology
  • Medicinal Chemistry

Background:

  • Human Immunodeficiency Virus (HIV) integrase (IN) is essential for viral DNA integration into the host genome.
  • IN is a critical target for developing novel anti-HIV and anti-AIDS therapeutics.
  • Structure-based drug design (SBDD) approaches are being employed to discover IN inhibitors.

Purpose of the Study:

  • To review computer-aided drug design (CADD) efforts targeting HIV IN.
  • To provide an overview of HIV life cycle, IN mechanism, and relevant biological and cell-based assays.
  • To discuss available 3D structures of HIV IN and critique SBDD strategies.

Main Methods:

  • Review of computer-aided drug design strategies for HIV IN.
  • Analysis of ligand-based (pharmacophore) and target-based (docking) SBDD methods.

Related Experiment Videos

  • Discussion of computational chemistry studies on HIV IN.

    • Main Results:

    • HIV IN is a validated target for anti-HIV drug discovery.
    • Various CADD approaches, including pharmacophore modeling and molecular docking, have been applied to HIV IN.
    • Computational studies provide insights into inhibitor design and activity.

    Conclusions:

    • CADD offers a powerful strategy for the development of novel HIV IN inhibitors.
    • Understanding HIV IN structure and function is crucial for rational drug design.
    • Continued research in computational chemistry will advance the discovery of effective anti-HIV therapeutics.